溶瘤病毒免疫治疗市场研究报告按癌症类型（黑色素瘤、肺癌、乳腺癌、结直肠癌、前列腺癌）、按病毒类型（单纯疱疹病毒、腺病毒、呼肠孤病毒、牛痘病毒、新城疫病毒）、按给药途径（瘤内、静脉内、腹膜内、皮下）、按技术（转基因病毒、野生型病毒）按地区（北美、欧洲、南美、亚太地区、中东和非洲）- 到 2034 年的预测
ID: MRFR/HC/32294-HCR | 100 Pages | Author: Rahul Gotadki| August 2025
| Report Attribute/Metric | Details |
| Market Size 2024 | 4.40 (USD Billion) |
| Market Size 2025 | 5.26 (USD Billion) |
| Market Size 2034 | 26.39 (USD Billion) |
| Compound Annual Growth Rate (CAGR) | 19.62 % (2025 - 2034) |
| Report Coverage | Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
| Base Year | 2024 |
| Market Forecast Period | 2025 - 2034 |
| Historical Data | 2020 - 2024 |
| Market Forecast Units | USD billion |
| Key Companies Profiled | Grey Aviation, AbbVie, Fortress Biotech, SillaJen, Aslan Pharmaceuticals, Celgene, Virotherapy, Oncolytics Biotech, Bristol-Myers Squibb, Eli Lilly, Transgene, Merck, Targovax, Amgen, Reolysin |
| Segments Covered | Type of Cancer, Virus Type, Route of Administration, Technology, Regional |
| Key Market Opportunities | Innovative therapeutic combinations, Expanding clinical trial pipelines, Increasing cancer prevalence, Growing investment in research, Advances in viral engineering |
| Key Market Dynamics | Rising cancer prevalence, Increased R investment, Favorable regulatory environment, Growing patient awareness, Advancements in viral engineering |
| Countries Covered | North America, Europe, APAC, South America, MEA |
Frequently Asked Questions (FAQ) :
The Oncolytic Virus Immunotherapy Market is expected to be valued at 26.39 USD billion in 2034.
The projected CAGR for the Oncolytic Virus Immunotherapy Market from 2025 to 2034 is 19.62%.
North America is anticipated to dominate the Oncolytic Virus Immunotherapy Market with a value of 7.68 USD billion in 2032.
The market valuation for Melanoma in the Oncolytic Virus Immunotherapy Market was 0.92 USD billion in 2023.
Major players in the Oncolytic Virus Immunotherapy Market include AbbVie, Fortress Biotech, Oncolytics Biotech, and Bristol-Myers Squibb.
The expected market size for Breast Cancer in the Oncolytic Virus Immunotherapy Market is projected to be 3.095 USD billion by 2032.
The market for Colorectal Cancer in the Oncolytic Virus Immunotherapy Market is expected to be valued at 1.812 USD billion in 2032.
The market size for the APAC region in the Oncolytic Virus Immunotherapy Market was 0.56 USD billion in 2023.
The growth potential for Lung Cancer in the Oncolytic Virus Immunotherapy Market is significant, with an expected increase to 2.718 USD billion by 2032.
The market size for Prostate Cancer in the Oncolytic Virus Immunotherapy Market was 0.603 USD billion in 2023.
Comments
Leading companies partner with us for data-driven Insights.
Kindly complete the form below to receive a free sample of this Report
